人皮肤成纤维细胞-新生儿Human Dermal Fibroblasts – Neonatal, Primary

¥7038.90
Lifeline Cell Technology
美国
2021-09-08 03:51

北京清源浩生物科技有限公司

我要认领
北京清源浩生物科技有限公司
郭经理
13488766924 01051177251
854837567@qq.com
产品属性
英文名Human Dermal Fibroblasts – Neonatal, Primary
数量库存或订购
供应商北京清源浩生物科技有限公司
细胞类型原代细胞
组织来源人正常皮肤
相关疾病
物种来源
免疫类型参见说明书
细胞形态见说明书
器官来源
运输方式液氮或干冰
年限液氮储存10年以上
生长状态贴壁生长
规格500,000 cells
产品说明

相关产品: 培养试剂成纤维细胞培养基

Lifeline® Normal Human Skin Fibroblasts – Neonatal (HDFn) provide an ideal cell system to establish serum free human feeder layers for human embryonic stem cell cultures or as a model to study wound healing, toxicology or basic cell biology.

Lifeline® Dermal Fibroblasts – Neonatal are isolated from neonatal human foreskin and cryopreserved as primary cells to ensure the highest viability and plating efficiency.

  • Our skin fibroblasts are quality tested in FibroLife® S2 or FibroLife Xeno-Free Medium to ensure proper growth and morphology over a period of at least 15 population doublings.
  • Lifeline® dermal fibroblasts tested in both FibroLife® Serum-Free Medium and FibroLife® S2 Medium display optimal growth at rates equal to or greater than classical serum-supplemented medium.

500,000 cells per vial

Lifeline® dermal fibroblasts – neonatal are not exposed to antimicrobials or phenol red when cultured in the appropriate Lifeline FibroLife® medium, an advantage since these supplements can cause cell stress and “masking effects” that may negatively impact experimental results.

Dermal fibroblasts are quality tested for:

  • Cell Viability: Minimum 70% viability when thawed from cryopreservation
  • Sterility Testing: Negative for mycoplasma. Negative for bacterial and fungal growth.
  • Virus Testing: Negative for HIV-1, HIV-2, HBV, and HCV by PCR